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Abstract
Introduction: The period, from exposure to a potential pathogen to the manifestation of symp-
toms i.e. incubation period, is time the virus spends replicating in the host. An estimation of 
this period and subsequent quarantine of the host can limit potential spread, particularly in 
asymptomatic carriers. Effective contact tracing, length of self-quarantine, repeat testing and 
understanding of disease transmission are all contingent on a true estimation of this incubation 
period.
Methods: Articles in English from December 1st , on Google scholar, PubMed, Research gate 
along with bulletins from WHO and the CDC were queried for the keywords, “SARS-CoV-2”, 
“COVID-19”, “median incubation period”, “mean incubation period”, “symptom onset”, “quar-
antine” and “exposure interval’’ and reviewed independently by two authors to establish con-
sensus. Travel to Wuhan, or in absence of travel, the earliest possible exposure, were used to 
calculate mean or median incubation period. Correspondingly, we reviewed the advised lengths 
of quarantine period.
Results: Five studies with a combined sample size of 505 patients were reviewed for mean/
median incubation period. Four studies recommended periods for self-quarantine, ranging from 
2- 14 days. Linton et al. recommended the shortest estimate of the median incubation period at 
4.3 days (95% CI 4.5-5.6), whereas the longest was by Backer et al. at 6.4 days (95% CI 4.5-
5.8). Similarly, the shortest estimation of mean incubation period was by Liu et al. (n=16) at 4.8 
days (95% CI 2.2-7.4) days while the longest at 5.5 days (95% CI 4.5-5.8) was by Lauer et al. 
(n=181). Although the range for quarantine in these four studies was 12.5 to 14 days, all four 
recommended 14 days as the optimum for self-quarantine.
Conclusion: A precise estimate of incubation period is instrumental in outlining an effective 
quarantine measure. Calculation of the incubation period using mathematical models has es-
tablished an accurate measure, albeit with uncertainty increasing towards the tail of each dis-
tribution. Based on a thorough review of these studies a quarantine period of 14 days can be 
recommended allowing 97.5% of the infected people to show symptoms. These symptomatic 
patients would be further evaluated based on their respective state health guidelines so that 
they may be effectively isolated and treated.
Introduction
The geographic spread of COVID-19 pandemic highlights the need to study the natural 
history and incubation period of SARS-CoV-2. Incubation period is defined as the period 
between exposure to an infectious agent and the development of the first symptom. [1] 
A precise calculation of the incubation period is critical in estimating the time required 
for disease monitoring, restriction of movement of people (quarantine), estimating the 
extent of the pandemic and predicting the temporal spread of the disease. [2,3] An ac-
curate incubation period can be used effectively for carrying out contact tracing and re-
stricting the point of entry in several countries, while enabling a better understanding of 
the disease transmission as well. [4,5]
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The migration of patients to an affected area presents the rare advantage of limiting the probability of time of exposure 
and contraction of the virus to the duration of stay, thereby enabling the precise calculation of the incubation period. 
This in turn allows us to understand and predict the course of the pandemic.
The purpose of the review article is to evaluate the role that the incubation period and to arrive at a consensus for an 
effective public health measures to prevent disease transmission.
Methods
The Databases- Google scholar, PubMed, Research gate, WHO and the CDC with the key words- “SARS-CoV-2”, 
“COVID-19”, “median incubation period”, “mean incubation period”, “symptom onset”, “quarantine” and “exposure 
interval” were queried. The resulting original research study articles, case series and case reports were considered 
along with public health news bulletins from the WHO and the CDC. Two authors independently reviewed the full text 
of each article and any discrepancies were resolved by discussion to reach a consensus. For each article, we recorded 
the travel history to Wuhan, mean or median incubation period, the time to symptom onset, time to hospitalization and 
the possible range of the incubation periods obtained. Only articles where the incubation period fit into a lognormal, 
Weibull or gamma distribution were used. We also recorded the advised quarantine periods in each article when avail-
able. In cases where there was no travel history to Wuhan, but exposure to an infectious source was present, the possi-
ble interval of SARS-CoV-2 exposure was taken as the maximum possible interval of exposure to the infectious person, 
including the time before the person was asymptomatic. All articles considered had cases reported at the earliest on 
December 1, 2020 and in continuum to present day. Our exclusion criteria included all articles in any language other 
than English, research articles that used data for incubation period calculation after the commencement of community 
transmission in the respective country of study.
Results
Five original research studies were analyzed for the mean or median incubation period. Four of them gave quarantine 
period recommendations (Table 1). The combined sample size of these studies were 505 patients over the course of 
January, February and March of 2020.
The shortest observed incubation period was 2 days and the longest, 14 days. The shortest estimate of the median of 
incubation period was by Linton et al. at 4.3 days (95% CI 4.5-5.6), whereas the longest was by Backer et al. at 6.4 days 
(95% CI 4.5-5.8). Similarly, the shortest estimation of mean of the incubation period was by Liu et al. (n=16) at 4.8 days 
(95% CI 2.2-7.4) days while the longest stands at 5.5 days (95% CI 4.5-5.8) from a study by Lauer et al. (n=181). The range 
of quarantine periods estimated in four independent studies was between 12.5 - 14 days (Figure 1).
Table 1. Summary of incubation periods and recommended quarantine length
Name Sample size (n) Range of incubation period
Mean/median 
incubation period





Linton et al.(2) 210 2-14  Median - 4.6 95% (3.7-5.7) 14
Linton et al.(2) 210 2-14 Mean - 5.6 95% (4.4-7.4) 14
Backer et al.(6) 88 2.1-11.1  Median - 6.4 95% (5.6-7.7) 14.1
Lauer et al.(8) 181 2.2-11.5  Median - 5.1Mean - 5.5
95% (4.5-5.8)
n/a 14
Li et al.(7) 10 n/a  Mean - 5.2 95% (4.1-7.0) 12.5
Liu et al.(20) 16 2-11  Mean - 4.8 95% (2.2-7.4) n/a
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Figure 1. Range of confidence interval (CI) of median incubation period
Discussion
Very few studies have been done to establish the mean, median and range of incubation periods. This has primarily 
been secondary to the difficulty of contact tracing to determine the time of exposure and because of community based 
spread of the virus to regions outside Wuhan. Most studies conducted had their patient pool from the Hubei province 
of China with only two studies assessing the incubation period length in patients outside Wuhan where the pandemic 
broke out.
Li et al. evaluated the incubation period by assessing 10 patients. They established an incubation period of 5.2 days 
(95% CI 4.1-7.0) with 95% of the patients presenting with symptoms before 14 days. [6] This observation formed the 
original basis for the proposed 14-day quarantine period. [7] This study however included only the patients who were 
residents of Wuhan and had an exposure to the seafood market linked to the virus outbreak and did not include visitors.
In contraste, Linton et al. (n=210) included residents of Wuhan as well as travelers to the city in their study. The Bayes-
ian estimates for incubation period were obtained by fitting the probability density function along lognormal, Weibull 
and gamma distributions, of which the lognormal distribution was found to best fit the data. Through this, the mean 
incubation period was found to be 5.6 days (95% CI 5.0-6.3) when Wuhan residents were included and 5.0 days (95% 
CI 4.2-6.0) when they were excluded. With right truncation, this figure increased to 5.6 (95% CI 4.4-7.4). [2] Similarly, 
the median incubation period was found to be 5.0 (95% CI 4.4-5.6) when Wuhan residents were included and 4.3 (95% 
CI 3.5-5.1), when they were excluded with right truncation again increasing the incubation period to 4.6 days (95% CI 
3.7-5.7). [2]
The exclusion of Wuhan residents therefore provided a more accurate result when one considers the difficulty in trac-
ing contacts among people who have resided over a long time-period in the city and the larger points of contact they 
may have had with infectious sources. Moreover, the occurrence of local transmission makes the period of exposure 
less firm in these patients. Consequently, this study had the overall advantage of additional case data and fitted left 
exposure dates, when compared to an earlier study by Backer et al. based on the same model, where unknown left ex-
posure dates were fixed during analysis. Despite this drawback, the study by Backer et al. yielded similar results with 
the mean incubation period estimated to be 6.4 days (95% CI 5.6-7.7) in a Weibull distribution which, in contrast to the 
study by Linton et al. used a Lognormal distribution and allowed a better fit for the data. [6]
Lauer et al. analyzed cases from Wuhan and from outside the city (n=181). The study showed a median incubation pe-
riod 5.0 days (95% CI 4.4-5.6) within a range of 2-14 days for patients outside China (mostly travelers to Wuhan) com-
pared to 4.8 days (95% CI 4.2-5.6) within a span of 2.5-9.2 days for mainland Chinese patients. [8] This stands in stark 
contrast with the earlier study by Linton et al. where the incubation period for the pool with patients from Hubei was 
longer compared to the pool constituting travelers from outside.
Establishing a Quarantine Period
It appears that the estimates of the incubation period are accurate and allow establishing a quarantine period to slow 
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the spread of the pandemic. Li et al were the first to note that 95% of their patients presented with symptoms before 
day 14. [6,7] This formed the original basis for the most frequently used quarantine period of 14 days. Backer et al. whose 
results showed that 99% of their study patients presented with symptoms within 12 days of infectious source exposure. 
[6] Only one study, by Linton et al. presented data wherein 5% of the study patients presented after day 14 and 1%, after 
day 19 of incubation with symptoms. However, with 95% of their patients having presented within 12.3 days (95% CI 
9.1-19.8), the authors agreed that a 14 days quarantine period would be adequate to contain the spread of the disease. [2] 
Lauer et al. advocated that a 14-day quarantine period was adequate to isolate infected patients with only 101 out of 
every 10,000 cases (99th percentile, 482) developing symptoms after 14 days of active monitoring or quarantine. It was 
found to be highly unlikely that further symptomatic infections would be undetected among high-risk persons with a 
mean of 1.0 undetected infections per 10,000 persons with the current 14-day quarantine guideline. Extended quaran-
tine was advised only in extreme cases or heavily impacted geographic regions with a judgement based on the cost of 
missing out cases. [8] Indeed, a 14-day quarantine for people who are suspected of being exposed to SARS-CoV-2 has 
been established as one of the most effective public health measures to contain the ongoing COVID-19 pandemic. 
Challenges in estimating the Incubation Period
Despite efforts to make a precise and accurate calculation of the incubation period for SARS-CoV-2 a detailed review 
of current literature has determined certain drawbacks in the methods used. An infection event in most cases cannot 
be directly observed and the presence of multiple contacts has limited straightforward estimation, with this being es-
pecially true among residents of an affected region. Additionally, the crude incubation period has been difficult to esti-
mate even among travelers with known sources of exposure when the length of travel with the infectious source is long. 
[9] Finally, in all mentioned studies, the possibility of an asymptomatic infection and carrier state have not been taken 
into account due to only recent evidence suggesting the plausibility of such a state. [10-12]
Asymptomatic transmission compounded by the high viral shedding exhibited during the incubation period of SARS-
CoV-2 has raised concerns on the validity of determining the quarantine period based on incubation period alone. [13] 
Many countries are increasingly adopting additional public health measures such as a region-wide lockdown to factor 
in and compensate for the uncertainties in reaching an effective quarantine period and the challenges in diagnosing 
contagious asymptomatic patients in latent periods. [14-16] This has prompted some experts to advise mandatory test-
ing of close contacts whether immunologic or radiographic to eliminate the possibility of transmission through viral 
shedding during incubation period and mitigate public risk. [15,17-19]
In conclusion, it is imperative to have estimates that are reliable for taking necessary measures in prevention of the 
pandemic spread. Calculation of the incubation period using mathematical models has established an accurate mea-
sure, with uncertainty increasing towards the tail of each distribution. The estimates from four different studies have 
allowed us to reach a consensus on the quarantine period. Fourteen days in quarantine have been recommended, allow-
ing 97.5% of the infected people to develop symptoms. It is assumed that symptomatic persons will further be evaluated 
and further quarantined based on respective state health guidelines thereby limiting the spread of the virus.
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